Search
Celularity Inc
CELUAdd to Watchlist
1.150USD
-0.030-2.54%
Close 09-23 16:00（ET）
33.29MMarket Cap
LossP/E TTM
Celularity Inc (CELU) Stock Price Target & Forecast
Target Price
6.000USD+714.44%
CELU Analyst Recommendation Trends
In the current month, CELU has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CELU average Analyst price target in the last month is 6.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
CELU Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q2
FY2025Q3
FY2025Q4
Forecast
-0.75
-1.50
-1.50
Actual
-1.02
-0.88
-0.86
Surprise
-36.15%
+41.61%
+42.73%
FAQs
What is Celularity Inc's price target?
Analysts forecast that Celularity Inc's price target is USD 6.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 6.00.